{"entity":{"id":"nct06835530","kind":"trial","name":"A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)","aka":[],"tldr":"A phase 2 trial of Geriatric assessment in Non-Hodgkin lymphoma, run by Fondazione Italiana Linfomi - ETS, now recruiting.","summary":"A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL) is a phase 2 interventional study registered as NCT06835530 by Fondazione Italiana Linfomi - ETS, with 47 participants planned, started 2025-04-09 and due to reach its primary completion in 2030-04. Interventions recorded: Rituximab + Golcadomide (CC-99282). Conditions recorded: Diffuse Large B Cell Non-Hodgkin Lymphoma.\n\nLinked to the technology Geriatric assessment because the registry's title names it (\"geriatric assessment\") and Non-Hodgkin lymphoma among its conditions. Registry record only: no result has been read by an editor.","status":"recruiting","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT06835530","url":"https://clinicaltrials.gov/study/NCT06835530"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["non-hodgkin-lymphoma"],"sections":[],"technologies":["geriatric-assessment"],"targets":[],"drugs":["golcadomide"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06835530","phase":"2","setting":"A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)","sponsor":"Fondazione Italiana Linfomi - ETS","enrolled":47,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06835530/","neighbours":{"cancer":[{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"technology":[{"id":"geriatric-assessment","kind":"technology","name":"Geriatric assessment","route":"/technologies/geriatric-assessment/"}],"drug":[{"id":"golcadomide","kind":"drug","name":"Golcadomide","route":"/drugs/golcadomide/"}]}}